It’s Pop Quiz Friday 8/3! Let’s see if you get it right!
Which of the following peels is the best option for treatment of this condition?
A. Trichloroacetic acid 10-25%
B. Baker Gordon Peel
C. Three coats of Tricholoracetic acid 35%
D. Trichloroacetic acid 50%
E. Tricholoracetic acid 35% + jessner's solution
To find out the correct answer and read the explanation, click here.
Brought to you by our Brand Partner
…
Which of the following peels is the best option for treatment of this condition?
A. Trichloroacetic acid 10-25%
B. Baker Gordon Peel
C. Three coats of Tricholoracetic acid 35%
D. Trichloroacetic acid 50%
E. Tricholoracetic acid 35% + jessner's solution
To find out the correct answer and read the explanation, click here.
Brought to you by our Brand Partner
… Continue reading "It’s Pop Quiz Friday 8/3! Let’s see if you get it right!"
A patient presents with nail findings seen here. Biopsy demonstrates fungus. The patient recently saw an add for a medication, Jublia (Efinaconazole). What is the medication of action?
A. Antifungal via inhibiting fungal lanosterol 14-alpha-demethylase
B. Inhibits squalene epoxidase
C. Inhibits DNA gyrase
D. Inhibits epithelial sodium channels
E. Binds ergosterol and forms por … 
Which of the following is true about this condition?
A. Histology will show amastagotes in plasma cells.
B. Cuture is performed on MacConkey agar.
C. Diagnosis may be made by sending a sample
for real-time PCR assay to the Centers for Disease Control and Prevention.
D. This condition does not typically resolve without treatment.
E. Treatment for cutaneous and … 
An 80-year-old man with Parkinson’s disease developed a new pruritic eruption with these cutaneous findings. What is the antigenic target of the autoantibodies generated in this condition
A. NC16A of BPAg1
B. NC16A of BPAg2
C. C-terminal of BPAg1
D. C-terminal of BPAg2
E. alpha-6-beta-4 integrin
To find out the correct answer and read t … 
This patient is not a candidate for systemic therapy and declines surgical treatment. Which of the following injectable agents is an oncolytic virus that is FDA-approved for inoperable disease?
A) Talimogene laherparepvec (T-VEC)
B) Interleukin-2
C) GM-CSF
D) Rose bengal
E) bacille Calmette-Guerin (BCG)
To find out the correct answer and … 